LPGO — Lipigon Pharmaceuticals AB Share News
0.000.00%
Last trade - 00:00- SEK1.64m
- -SEK8.58m
Brief: Lipigon Expected To Be Removed From Trading On Nasdaq Stockholm On May 18
Brief: Lipigon Proposes To Delist Company From Nasdaq First NGM
Brief: Lipigon Pharmaceuticals Oct-Dec Oper Loss At SEK 7.2 Mln
Brief: Lipigon Pharmaceuticals Aims To Reduce Cost Base By Two-Thirds
Brief: Lipigon Conducts Review Of Drug Development Projects, Takes Cost-Saving Measures
Brief: Lipigon Pharmaceuticals Q3 Operating Loss Widens To SEK 7.4 Mln
Brief: Lipigon Q2 Operating Loss NOK 8.5 Mln
Brief: Lipigon Pharmaceuticals Carries Out Directed Issue Of Shares To Underwriters
Brief: Lipigon Announces Preliminary Outcome Of The Rights Issue
Brief: Lipigon Q1 Operating Loss SEK 9.1 Mln
Brief: Lipigon Pharmaceuticals Raises Bridge Loan Of SEK 3.4 Mln
Brief: Lipigon Decides On Fully Guaranteed Rights Issue Of About SEK 37.4 Mln
Brief: Lipigon Appoints Johan Liwing As New CEO
Brief: Lipigon Pharmaceuticals Jul-Sep Operating Loss SEK 6.7 Mln
Brief: Lipigon Pharmaceuticals: Application For Development Support From European Innovation Council Denied
Brief: Lipigon Receives Milestone Payment Of USD 1 Mln
Brief: Lipigon Q1 Operating Loss Widens To SEK 7.4 Mln
Brief: Lipigon Collaborates With University Of Washington On Lung Damage Project
Brief: Lipigon Pharmaceuticals Q4 Oper Loss Narrows To SEK 7.8 Mln